This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Biogen Ma Inc., Bioverativ Therapeutics Inc.. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: The Innovative Contributions of Lily Zhu
Introduction
Lily Zhu is a prominent inventor based in Belmont, MA (US). She has made significant strides in the field of biotechnology, particularly in the purification of chimeric proteins. Her work has implications for improving factor VIII activity, which is crucial for various therapeutic applications.
Latest Patents
Lily Zhu holds a patent for the "Purification of chimeric FVIII molecules." This invention focuses on methods of purifying a chimeric protein by subjecting it to factor VIII-specific affinity chromatography and anion exchange chromatography (AEX). The chimeric protein, which includes a factor VIII protein or a fragment thereof, demonstrates enhanced factor VIII activity when purified using these methods.
Career Highlights
Lily Zhu is currently employed at Bioverativ Therapeutics Inc., where she continues to contribute to advancements in biotechnology. Her innovative approaches have positioned her as a key figure in her field, and her work is recognized for its potential impact on therapeutic solutions.
Collaborations
Lily collaborates with talented individuals such as Anxhela Kole and John D Kulman. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Lily Zhu's contributions to the field of biotechnology, particularly through her patent on chimeric FVIII molecules, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.